Work

28PD Identifying the correct patient (pt) population for ABT-414: Biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM)

Year: 2015

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv518.03

Authors: L. Roberts-Rapp, P. Ansell, R. Kular, M. Song, I. Sokolova, H.K. Gan, K.P. Papadopoulos, A.B. Lassman, R. Merrell, P. Kumthekar, A.M. Scott, E. Gomez, J. Fischer, A. Bhathena, K. Holen, R. Lai, D. Reardon, M. van den Bent

Institutions: AbbVie (United States), Abbott (United States), Austin Health, Olivia Newton-John Cancer Research Institute, South Texas Accelerated Research Therapeutics, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Columbia University, Endeavor Health, Northwestern University, Dana-Farber Cancer Institute, Erasmus MC Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2531668987

FWCI:

Cites:

Cited by: 2

Related to: 10